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5-Diazoimidazoles and 5-diazopyrazoles have been shown to react with acyl isothiocyanates yielding the
imidazo- and pyrazolo[5,1-d][1,2,3,5]thiatriazines stabilized by a nonbonded S/O interaction. In contrast
to acyl isothiocyanates, alkyl-, aryl-, and arylsulfonyl isothiocyanates do not react with 5-diazoazoles. The
nature and the strength of stabilizing intramolecular interaction between non-bonded S and O atoms
have been studied by X-ray analysis for mono crystals and DFT calculations for selected azolo[5,1-d]
[1,2,3,5]thiatriazines. The interaction was described in terms of Weinhold covalence ratio factors, NBO,
and AIM schemes. The reaction discovered was used to develop an efﬁcient approach toward the new 8-
substituted 4-ethoxycarbonylimino-4-benzoyl- and 4-(3,4,5,6-tetraﬂuorobenzoyl)iminoimidazo(pyr-
azolo)[5,1-d][1,2,3,5]thiatriazines.
 2013 Elsevier Ltd. All rights reserved.N
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Scheme 1. Reactions of diazoimidazoles with isocyanates leading to mitozolomide 1a
(R¼CH2CH2Cl) and temozolomide 1b (R¼CH3).1. Introduction
1,3-Dipolar cycloaddition reactions of aliphatic diazo com-
pounds to triple and double bonds are well known and doc-
umented.1e3 They have beenwidely used in the synthesis of various
heterocyclic azoles. Thus, it is well known that an efﬁcient and
convenient method for the synthesis of 5-amino-1,2,3-thiadiazoles
includes the cycloaddition reactions of alkyl and aryl iso-
thiocyanates with aliphatic diazo compounds.4 Nevertheless, the
study of the cycloaddition reactions of aliphatic diazo compounds
as a model for various types of pericyclic processes continues to
interest physical organic chemists.5e8
Heterocyclic diazo compounds, where the a carbon atom has
been incorporated into the heteroaromatic system, are known to
react as 1,7-dipoles with electron-rich oleﬁns,9 acetylenes,1 and
isocyanates10e12 leading to six-membered heterocyclic com-
pounds. In comparison with aliphatic diazo compounds, hetero-
cyclic diazo compounds have been studied poorly. At the same
time, expanding the scope of the cycloaddition reaction of@ustu.ru (V.A. Bakulev).
All rights reserved.heterocyclic diazo compounds as an efﬁcient approach to fused
azoles is very important for medicinal chemistry. Reactions of 5-
diazoazoles with isocyanates are known to take place in very
mild conditions to afford azolo[5,1-d][1,2,3,5]tetrazines. Two com-
pounds of the imidazole series 1a,b exhibited a high level of anti-
tumor activity and have been used in both medicinal sciences and
practice (Scheme 1).13e15It is also reported that diazoimidazole 2a does not react with
methyl isothiocyanate either in Me2SO at 40 C or in an inert sol-
vent containing either the Lewis acids, such as zinc iodide and
boron triﬂuoride-etherate or triethylamine.16 The reasons for the
Table 1
Characteristics of azolo[5,1-d][1,2,3,5]thiatriazines 5
X Y R1 R2 Yield, % Duration of
reaction, h
5a CH N COOC2H5 OC2H5 79 18
5b CH N COOC2H5 C6H5 88 3.5
5c CH N CONHCH3 OC2H5 69 19
5d CH N CONHCH3 C6H5 76 3.5
5e CH N COPyrrolidinyl OC2H5 70 20
5f CH N COPyrrolidinyl C6H5 68 4
5g CH N COPiperidinyl OC2H5 73 20
5h CH N COPiperidinyl C6H5 78 4
5i CH N COMorpholinyl OC2H5 72 20
5j CH N COMorpholinyl C6H5 81 4
5k N CH COOC2H5 OC2H5 72 16
5l N CH COOC2H5 C6H5 84 3.5
5m N CeC6H5 H OC2H5 87 18
5n N CeC6H5 H C6H5 83 4
5o N CeC6H5 H C6HF4 78 6
5p N CeC6H4eCH3-p H OC2H5 96 15
5q N CeC6H4eCH3-p H C6H5 98 3
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Scheme 3. Reactions of diazoazoles 2bej with acylisothocyanates 4aec.
E.V. Sadchikova et al. / Tetrahedron 69 (2013) 6987e69926988different reactivity of isocyanates and isothiocyanates in their re-
action with diazoazoles are not rationalized.
In a preliminary report17 we described a new cycloaddition re-
action of 5-diazoazoles with benzoyl isothiocyanate leading to
a few examples of novel 1,2,3,5-thiatriazines fused to imidazole and
pyrazole rings. Interestingly, at the same time Ali Deeb and Mah-
mud Kolb published an alternative regiochemistry for the reaction
of 3-diazopyrazolo[3,4-c]pyridazine with phenyl- and ethox-
ycarbonyl isothiocyanates, leading to 1,2,3,5-triazine-4-thione de-
rivatives.18 These authors did not consider the possibility for
formation of a 1,2,3,5-thiatriazole in this reaction. Furthermore the
structures of the products prepared by these authors18 were con-
ﬁrmed by 1H NMR spectra only, which may not be conclusive proof
for such heteroatom-rich compounds. Therefore, for the better
understanding of the direction of cyclization and with the aim of
developing a general approach to azolo[1,2,3,5]thiatriazines we
have further studied the reaction of a series of 5-diazoimidazoles
and 5-diazopyrazoles, and 2-diazoimidazole-4,5-dicarbonitrile in-
volving apart of benzoyl isothiocyanate, tetraﬂuorobenzoyl, phe-
nylsulfonyl,- and ethoxycarbonyl isothiocyanates and have made
a careful study of the structures of the reaction products by X-ray
diffraction analysis, IR-, and NMR spectroscopy and theoretical
calculations. Special attention has been paid to the factors that
stabilize the reaction products because we have recently shown by
calculations with HartreeeFock and DFT methods19 that the re-
action of diazo compounds 5 with acyl isothiocyanates is thermo-
dynamically controlled.
2. Results and discussion
The starting 5-diazoimidazoles 2bef are prepared according to
a modiﬁed procedure20e23 by diazotization of the corresponding
amines 3bef in dilute hydrochloric acid with sodium nitrite at
5 C. It is worth noting that diazotization of 5-aminopyrazoles
3gej under these conditions leads to the corresponding pyr-
azolyl-5-diazonium salts, which can be easily transformed to 5-
diazopyrazoles 2gej by treatment of the reaction mixture with
10% sodium bicarbonate solution at pH 5.5, followed by extraction
with chloroform. The diazonium salts themselves are inert in the
investigated type of reactions.
In principle, both the C]N and C]S bonds of isothiocyanates 4
can take part in the cycloaddition reaction with diazoazoles 2 to
form either 1,2,3,5-thiatriazine 5 or 1,2,3,5-tetrazine 6 or their
mixture. In our preliminary report17 we have shown that both 5-
diazoimidazoles 2aef and 5-diazopyrazoles 2gej do not react
with methyl or phenyl isothiocyanates (Scheme 2).N
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Scheme 2. Synthesis of 5-diazoazoles.Now we have found that they also did not react with phenyl-
sulfonyl isothiocyanate bearing a strong electron acceptor sub-
stituent. Indeed, 3-methyl-, 3-phenylsulfonyl-, and 3-phenylazolo
[5,1-d][1,2,3,5]tetrazine-4(3H)-thiones of type 6 could not be pre-
pared in the same way as their oxygen analogs. In contrast to the
reactions with methyl- and phenyl isothiocyanate the analogous
reactions of diazoazoles 2bej with isothiocyanates containing
carbonyl groups, such as ethoxycarbonyl isothiocyanate 4a, benzoyl
isothiocyanate 4b and tetraﬂuorobenzoyl isothiocyanate 4c occur
readily in solution of anhydrous ethyl acetate to give azolo[5,1-d]
[1,2,3,5]thiatriazines 5 as the only products (Scheme 3, Table 1).5r N CeC6H4eCH3-p H C6HF4 83 5
5s N CeC6H4eOCH3-p H OC2H5 70 15
5t N CeC6H4eOCH3-p H C6H5 89 3
5u N CH COOC2H5 PhSO2 Is not
formedThe method of choice involves conducting the experiment at
room temperature, under an atmosphere of argon and in the ab-
sence of light. The use of other solvents increases the reaction time.
On the other hand, the increase of temperature leads to the for-
mation of tar-like products. The absence of oxygen and the pro-
tection of the reaction mixture from light diminish the
decomposition of the diazoazoles that may occur via the formation
of radicals. The completion of the reaction was estimated by the
disappearance of the diazo compound according to IR and TLC
analysis. The reaction time depends on the nature of the acyl iso-
thiocyanates and takes 3e3.5 h for benzoyl isothiocyanate 4b, 6 h
for tetraﬂuorobenzoyl isothiocyanate 4c and 15e20 h for the less
electron poor ethoxycarbonyl isothiocyanate 4a. It should be noted
that 2-diazoimidazole-4,5-dicarbonitrile is found to be inactive in
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and 5-diazopyrazoles do not react neither with alkyl- and aryl
isothiocyanates nor with phenylsulfonyl isocyanate in spite of the
latter containing a strong electron acceptor group, we have con-
cluded that the presence of the carbonyl group in the iso-
thiocyanate molecules is needed for their reaction with 5-
diazoazoles.
The thiatriazines 5aet are isolated in high yields (68e98 %) (See
Table 1) and gave satisfactory elemental analyses. The NMR spectra
for cycloadducts 5aet demonstrate that all of the compounds be-
long to the same structural typewith the same heterocyclic systems
present. Thus, the 1H NMR and 13C NMR spectra contain signals of
the substituents attached to either the azole rings or the imino
group of the thiatriazine ring. As expected, for fused azoles the
signal assigned to the azole proton of compounds 5aes is signiﬁ-
cantly shifted downﬁeld (Dd¼1.44e1.95 for proton and 29 ppm for
carbon NMR spectra, respectively) compared to the diazoazole
precursors 2bej. Signals at d¼176e180 ppm in compounds
5b,d,f,h,j,l,n,p,o,q,r,t are assigned to the benzoyl carbon, and the
signals at d¼160e162 ppm in 5a,c,e,g,i,k,m,p,s to the ethox-
ycarbonyl carbons and this is in agreement with literature data for
these groups in similar compounds.24,25
Signals at 155.1e160.8 ppm were assigned to carbons of the
C4]N groups of the 1,2,3,5-thiatriazine ring based on the careful
analysis for spectra of series of compounds 5aes. The signals
corresponding to C9 of the bicycle compounds 5 were observed
in broad region of 134e147 ppm depending on the substituents
and nature of azole rings.
We have shown by NMR study that compounds 5 are not stable
in the presence of water and alcohols therefore all NMR measure-
ments were made just after the samples were dissolved.
It is worth noting that all spectroscopic data are in good
agreement with both thiatriazine 5 and tetrazine 6 structures. The
ﬁnal decision in favor of structure 5 is made by single crystal X-ray
analysis, which was executed for the most stable pyrazolothia-
triazines 5k,l. Structural parameters for compounds 5k,l are given
in the Supplementary data and a view of compound 5k is depicted
in Fig. 1 and for compound 5l is available from our preliminary
study.17Fig. 1. Obtained geometry of ethyl 8-ethoxycarbonyl-iminopyrazolo[5,1-d][1,2,3,5]
thiatriazine-4-carboxylate 5k.According to the X-ray diffraction data, molecules 5k,l are in the
crystalline form a nearly planar structure. The maximum deviation
from the best plane through the heterocycle is 0.008(1)A for N5 in
5k and 0.038(2) A for C6 in 5l. The ﬁve- and six-membered rings
in 5lmake an angle of 1.68(8). Bond angles N2eN3eO12 are near to
180. The conﬁguration of the external imine substituent is Z and
the S1/O17 distance is 2.613(1)A in 5k and 2.496(1)A in 5l. This is
in both cases shorter than the sum of the corresponding van der
Waals radii (3.2 A), and in the case of 5l also shorter than the
Huggins constant energy distance of 2.58A,26 indicating a degree of
covalent bonding. Both short OeS contacts and near linear ar-
rangement of fragment NeSeO makes possible the overlapping of
a nonbonded orbital located on the oxygen of the carbonyl group
(nO/s*SeN).27
The study of so-called ‘nonbonded SeO interactions’ are of in-
terest both in theoretical and experimental research27e30 due to its
importance in different ﬁelds. For example, the consequence of the
presence of this type of interaction in certain compounds could be
the stabilization of isomers supporting a planar structure, that is,
required to interact with some enzymes and exhibit biological ac-
tivity.31 Thus, nonbonding sulfureoxygen interaction can control the
stereoselectivity of some reactions.32 Quite recently, the easiness of
oxidative cyclizationsofN-acyl 2-arylhydrazonothioacetamides to 5-
acylimino-2,5-dihydro-1,2,3-thiadiazoles was explained by the ex-
istence of very strong nonbonded SeO interactions and the aroma-
ticity of the reaction products.33
To evaluate these stabilizing SeO interactions quantitatively, the
difference of Gibbs energies for two conformations (DE) (See Table 2)
were calculated at the B3LYP/6-31G* level of theory. These data
conﬁrm that structures 5 with hypervalent thiadiazole sulfur atom
(conformation A) are more stable than the ones where nonbonded
S/O through-space interaction are absent (conformation B).SN
OR2
SNO
.
.
.
Conformation A Conformation B
Table 2
Quantum chemical descriptors calculated to describe the S/O interaction
n(S/O)a E(2)b r(SO)c a(NeSeO)d ce r(BCP)f RCPg DEh ti
5k 0.0695 5.58 2.62 178.5 0.489 2.606$102 þ 3.006 16
5l 0.0915 6.98 2.56 178.5 0.527 2.946$102 þ 5.023 3.5
5o 0.0844 7.02 2.59 178.8 0.511 2.793$102 þ 3.894 6.0
5u 0.0387 2.40 2.77 172.3 0.389 1.925$102 þ d d
a Wiberg bond indexes in the NAO basis (NBO, B3LYP/6-31þG**).
b The stabilization energy gained by donation from NBO of donor to NBO of ac-
ceptor, calculated with a help of second order perturbation theory in kcal/mol (NBO,
B3LYP/6-31þG**).
c S/O distance, in A (B3LYP/6-31þG**).
d Bond angle NeSeO, in  (B3LYP/6-31þG**).
e Covalency index as introduced by F. Weinhold.29
f The electron density in (3,1) bond critical point in a.u. (AIM, B3LYP/6-31þG**).
g ‘þ’ symbolizes that (3,þ1) ring critical point was located for SeCeNeCeO se-
quence (AIM, B3LYP/6-31þG**).
h The stabilization energy calculated as the difference in electronic energies be-
tween two conformers A and B and corrected with ZPE values, in kcal/mol (B3LYP/6-
31þG**).
i The reaction time, h.
E.V. Sadchikova et al. / Tetrahedron 69 (2013) 6987e69926990The beneﬁt of stabilization, quantitatively expressed as an en-
ergy difference between two conformations, was decreasing in the
series 5l>5o>5k. It should be mentioned that two equal confor-
mations A and A0were found for 5u (See Supplementary data for 3D
representations of located structures). As a result, no energy dif-
ference DE was calculated for 5u (Table 2). Analysis of the length
differences for bonds C]O, C]N, and CeN of conformations A and
B calculated at the B3LYP/6-31G* level of theory for compounds
5k,l,o has shown that they are slightly distorted in conformation A.
The double bonds became longer and CeN single bonds shorter in
comparison with conformation B for 0.01e0.027 A (See Table 2).
Calculated dseo distances were used to obtain the Weinhold
covalence ratio factors c29 for these compounds. Values were
varying in a 0.389e0.527 interval (See Table 2), suggesting that the
strongest S/O interactions are to be found in 5l and 5o.
The expansion of the oxygen lone pair electron density to vacant
s*(SeN) orbital was studied within an NBO (Natural Bond Orbitals)
framework34 (See Fig. 2). The Wiberg bond indexes and electron
population for the corresponding atoms were also calculated.
Second order perturbation theory analysis of the Fock matrix in
a NBO basis was applied to estimate the stabilization energy, E(2)
gained as a result of electron delocalization from one orbital to
another (See Table 2). Correlating experimentally observed reaction
time and calculated stabilization descriptors, one can see that
stronger S/O interaction correlates with lower reaction time. For
example, compound 5l reacts faster and has a higher Wiberg bond
index n, energy of n/s* interaction E(2), covalency ratio factor c,
and energy stabilization DE comparing to compounds 5o and 5k.
Remarkably, the compound 5u bearing arylsulfonyl group at ni-
trogen atom that was not formed in reaction of diazo compounds 2
with phenylsulfonyl isocyanate, distinguished drastically from
5k,l,o in respect of all calculated characteristics (See Table 2). The
existence of S/O dative bond and formation of new cyclic fragment
within the molecule were also conﬁrmed in AIM (Atoms in Mole-
cule) notations.35 The (3,1) bond critical points of r for S/O bond
and the (3,þ1) ring critical points for ﬁve-membered rings con-
taining sulfur and oxygen atoms were located for all selected cal-
culated structures (See Table 2). Thus, all quantum chemical
descriptors, used to describe the S/O interaction, advocate that
compounds 5 contain a pseudoheterocyclic oxathiazole ring fused
to the 1,2,3,5-thiatriazine ring and thus are similar in this respect to
the family of thiapentalenes.27 To the best of our knowledge, this is
the ﬁrst example of the existence of a relatively strong SeO in-
teraction, where sulfur belongs to a six-membered ring.Fig. 2. n(O)/s*(SN) interaction shown in NBO orbitals (B3LYP/6-31þG**) of com-
pound 5l.This newly discovered reaction represents the ﬁrst example of
cycloaddition of diazoazoles to a C]S bond. It is worth mentioning
that 1,2,3,5-thiatriazines fused to any heterocycles were not knownfrom the literature and examples ofmonocyclic 1,2,3,5-thiatriazines
are limited to a very few compounds described in a single paper.36
The acyl substituent on the isothiocyanate led to a stabilization
of the ﬁnal product 5 due to an S/.O interaction, which is in
agreement with both X-ray data for thiatriazines 5k,l and calcula-
tions of the structures of 5k,l,o,u. Probably this is the main reason
of the difference in the reactivity of acyl isothiocyanates and alkyl
and aryl isothiocyanates in their reaction with diazoazoles and this
may be the driving force for the reaction.
3. Conclusions
In summary, we have developed an efﬁcient method for the
synthesis of imidazo- and pyrazolo[5,4-b][1,2,3,5]thiatriazines
based on cycloaddition reaction of diazoazoles with acyl iso-
thiocyanates. The prepared compounds are shown by both X-ray
data for thiatriazines 5k,l and by calculations for the structures
5k,l,o to have relatively strong SeO nonbonded interactions. These
studies reveal that the introduction of an acyl group to the nitrogen
atom of isothiocyanates is essential for the formation of the thia-
triazine ring in the studied reactions with diazoazoles.
4. Experimental section
4.1. General
IR spectra were recorded on a Perkin Elmer 1600 Series FTIR in
KBr pellets. The 1H and 13C NMR spectra were recorded in [2H6]
DMSO solution with Bruker WR-300 and Bruker DRX-400, 300 and
400 MHz for 1H, 75 and 100 MHz for 13C using TMS as internal
standard. X-ray diffraction measurements were made on a Bruker
SMAART 6000 diffractometer equipped with CCD detector using
CuKa radiation (l¼1.54178 A).
4.2. General procedure for the synthesis of the azolo[5,1-d]
[1,2,3,5]thiatriazines (5aet)
The corresponding acyl isothiocyanate 4aec (1.0 mmol) in an-
hydrous ethyl acetate (3 mL) was added to a cooled solution of 5-
diazoazole 2bej (0.5 mmol) in anhydrous ethyl acetate (5 mL), in
a dropwise manner at 10 C, in the dark. The mixture was stirred
at room temperature until the compounds 2 according TLC analysis
taken disappeared. Then, activated charcoal was added and the
mixture was ﬁltered. Then, the solvent was removed in vacuo
(temperature<40 C). The residuewas trituratedwith diethyl ether
or hexane, collected, air-dried, and puriﬁed by ﬂash chromatogra-
phy with CH3COOC2H5/CH2Cl2 as the eluant to give 5aet.
4.2.1 (Z)-Ethyl 4-(ethoxycarbonylimino)-4H-imidazo[5,1-d][1,2,3,5]
thiatriazine-8-carboxylate (5a). Yield 0.12 g (79%), mp 101e102 C;
nmax (KBr), cm1: 1677.2, 1728.6, 2932.2, 2980.0, 3068.2, 3128.1; dH
(300.13 MHz, DMSO-d6, 300 K): 1.27 (3H, t, J 7.3 Hz, OCH2CH3), 1.35
(3H, t, J 7.3Hz,OCH2CH3), 4.29 (2H, q, J 7.3Hz, OCH2CH3), 4.44 (2H, q, J
7.3 Hz, OCH2CH3), 9.14 (1H, s, 6-H); dC (75.4 MHz, DMSO-d6, 300 K):
13.9, 14.1, 61.5, 63.6, 131.5, 134.3, 134.6, 158.1, 160.0, 160.1. Calcd for
C10H11N5O4S: C, 40.40; H, 3.73; N, 23.56; S,10.79. Found: C, 40.43; H,
3.80; N, 23.54; S, 10.76.
4.2.2 (Z)-Ethyl 4-(benzoylimino)-4H-imidazo[5,1-d][1,2,3,5]thia-
triazine-8-carboxylate (5b)17 and (Z)-Ethyl 8-(methylcarbamoyl)-4H-
imidazo[5,1-d][1,2,3,5]thiatriazin-4-ylidenecarbamate (5c). Yield
0.10 g (69%), mp 115e116 C; nmax (KBr), cm1: 1655, 1680, 2940,
2980, 3100, 3120; dH (400.13 MHz, DMSO-d6, 298 K): 1.30 (3H, t, J
7.0 Hz, OCH2CH3), 2.86 (3H, d, J 4.7 Hz, NHCH3), 4.29 (2H, q, J7.0 Hz,
OCH2CH3), 8.67 (1H, q, J 4.7 Hz, NHCH3), 9.15 (1H, s, 7-H); dC
(100.62 MHz, DMSO-d6, 298 K): 13.9, 26.0, 63.4, 131.1, 132.6, 137.9,
E.V. Sadchikova et al. / Tetrahedron 69 (2013) 6987e6992 6991158.3, 159.6, 159.9. Calcd for C9H10N6O3S: C, 38.30; H, 3.57; N,
29.77; S, 11.36. Found: C, 38.40; H, 3.54; N, 29.82; S, 11.40.
4.2.3 (Z)-4-(Benzoylimino)-N-methyl-4H-imidazo[5,1-d][1,2,3,5]thia-
triazine-8-carboxamide (5d)17 and (Z)-Ethyl 8-(pyrrolidine-1-
carbonyl)-4H-imidazo[5,1-d][1,2,3,5]thiatriazin-4-ylidenecarbamate
(5e). Yield 0.11 g (70%),mp99e100 C; nmax (KBr), cm1: 1675, 2880,
2960, 2975, 3130; dH (250.13 MHz, DMSO-d6, 298 K): 1.30 (3H, t, J
7.0 Hz, OCH2CH3),1.85e1.93 (4H,m, 2CH2), 3.51e3.58 (4H,m, 2CH2),
4.28 (2H, q, J 7.0 Hz, OCH2CH3), 9.13 (1H, s, 6-H); dC (100.62 MHz,
DMSO-d6, 298 K): 13.9, 23.7, 25.6, 46.0, 48.0, 63.4,131.2,132.3,141.0,
158.4,159.4,160.0. Calcd for C12H14N6O3S: C, 44.71;H, 4.38;N, 26.07;
S, 9.95. Found: C, 44.78; H, 4.40; N, 26.02; S, 10.02.
4.2.4 (Z)-N-(8-(Pyrrolidine-1-carbonyl)-4H-imidazo[5,1-d][1,2,3,5]
thiatriazin-4-ylidene)benzamide (5f)17 and (Z)-Ethyl 8-(piperidine-1-
carbonyl)-4H-imidazo[5,1-d][1,2,3,5]thiatriazin-4-ylidenecarbamate
(5g). Yield 0.12 g (73%), mp 103e104 C; nmax (KBr), cm1: 1680,
2860, 2930, 2960, 3130; dH (400.13 MHz, DMSO-d6, 298 K): 1.30
(3H, t, J 7.0 Hz, OCH2CH3), 1.48e1.47 (2H, m, CH2), 1.65e1.59 (4H,
m, 2CH2), 3.41e3.38 (2H, m, CH2), 3.69e3.67 (2H, m, CH2), 4.28
(2H, q, J 7.0 Hz, OCH2CH3), 9.12 (1H, s, 6-H); dC (100.62 MHz,
DMSO-d6, 298 K): 13.9, 23.8, 25.3, 26.2, 42.3, 47.5, 63.4, 131.5,
132.0, 140.9, 158.3, 159.9, 160.0. Calcd for C13H16N6O3S: C, 46.42;
H, 4.79; N, 24.98; S, 9.53. Found: C, 46.40; H, 4.82; N, 25.03; S,
9.50.
4.2.5 (Z)-N-(8-(Piperidine-1-carbonyl)-4H-imidazo[5,1-d][1,2,3,5]
thiatriazin-4-ylidene)-benzamide (5h)17 and (Z)-Ethyl 8-(morpho-
l ine-4-carbonyl)-4H-imidazo[5,1-d][1,2,3,5]thiatriazin-4-
ylidenecarbamate (5i). Yield 0.12 g (72%), mp 96e98 C; nmax (KBr),
cm1: 1675, 2850, 2915, 2975, 3140; dH (400.13 MHz, DMSO-d6,
298 K): 1.30 (3H, t, J 7.0 Hz, OCH2CH3), 3.51e3.50 (2H, m, CH2),
3.56e3.55 (2H,m, CH2), 3.72e3.70 (4H,m, 2CH2), 4.28 (2H, d, J 7.0Hz,
OCH2CH3), 9.14 (1H, s, 6-H); dC (100.62 MHz, DMSO-d6, 298 K): 13.9,
42.1, 47.0, 63.4, 66.0, 66.4, 131.5, 132.4, 139.8, 158.2, 160.0, 160.1.
Calcd for C12H14N6O4S: C, 42.60; H, 4.17; N, 24.84; S, 9.48. Found: C,
42.66; H, 4.20; N, 24.80; S, 9.44.
4.2.6 (Z)-N-(8-(Morpholine-4-carbonyl)-4H-imidazo[5,1-d][1,2,3,5]
thiatriazin-4-ylidene)benzamide (5j)17 and (Z)-Ethyl 4-(ethox-
ycarbonylimino)-4H-pyrazolo[5,1-d][1,2,3,5]thiatriazine-8-
carboxylate (5k). Yield 0.11 g (72%), mp 110e112 C; nmax (KBr),
cm1: 1666.0,1708.7, 2910.5, 2992.9, 3110.2, 3395.9; dH (300.13MHz,
DMSO-d6, 300 K): 1.30 (3H, t, J 7.0 Hz, OCH2CH3), 1.36 (3H, t, J 7.0 Hz,
OCH2CH3), 4.28 (2H, q, J 7.0 Hz, OCH2CH3), 4.42 (2H, q, J 7.0 Hz,
OCH2CH3), 8.78 (1H, s, 7-H); dC (75.4 MHz, DMSO-d6, 300 K): 14.8,
15.0, 62.3, 64.3, 116.0, 143.5, 146.6, 160.8, 161.5, 161.5. Calcd for
C10H11N5O4S: C, 40.40; H, 3.73; N, 23.56; S,10.79. Found: C, 40.32; H,
3.70; N, 23.63; S, 10.91.
4.2.7 (Z)-Ethyl 4-(benzoylimino)-4H-pyrazolo[5,1-d][1,2,3,5]thia-
triazine-8-carboxylate (5l)17 and (Z)-Ethyl 7-phenyl-4H-pyrazolo[5,1-
d][1,2,3,5]thiatriazin-4-ylidenecarbamate (5m). Yield 0.13 g (87%),
mp 182e184 C; nmax (KBr), cm1: 1710, 1760, 2350, 2975, 3140; dH
(300.13 MHz, DMSO-d6, 300 K): 1.37 (3H, t, J 7.0 Hz, OCH2CH3), 4.30
(2H, q, J 7.0 Hz, OCH2CH3), 7.49e7.58 (3H, m, 30,40,50-H), 8.15 (2H, d, J
9.8 Hz, 20,60-H), 8.33 (1H, s, 8-H); dC (75.4 MHz, DMSO-d6, 300 K):
14.0, 63.1, 110.1, 126.7, 129.1, 129.7, 129.2, 130.6, 145.9, 155.2, 160.8.
Calcd for C13H11N5O2S: C, 51.82; H, 3.68; N, 23.24; S,10.64. Found: C,
51.88; H, 3.69; N, 23.07; S, 10.58.
4.2.8 (Z)-N-(7-Phenyl-4H-pyrazolo[5,1-d][1,2,3,5]thiatriazin-4-
ylidene)benzamide (5n). Yield 0.14 g (83%), mp 196e198 C; nmax
(KBr), cm1: 1745, 2915, 2325, 2350, 3115; dH (300.13 MHz, DMSO-
d6, 300 K): 7.53e7.61 (5H, m, 30,40,50,300,500-H), 7.66e7.69 (1H, m, 400-H), 8.22 (2H, d, J 7.9 Hz, 20,60-H), 8.34 (2H, d, J 7.0 Hz, 200,600-H), 8.39
(1H, s, 8-H); dC (75.4 MHz, DMSO-d6, 300 K): 110.1, 126.8, 129.1,
129.3, 129.4, 130.2, 130.6, 133.7, 134.3, 146.1, 155.2, 177.1. Calcd for
C17H11N5OS: C, 61.25; H, 3.33; N, 21.01; S, 9.62. Found: C, 61.29; H,
3.35; N, 21.06; S, 9.59.
4.2.9 (Z)-2,3,4,5-Tetraﬂuoro-N-(7-phenyl-4H-pyrazolo[5,1-d][1,2,3,5]
thiatriazin-4-ylidene)benzamide (5o). Yield 0.16 g (78%), mp
187e189 C; nmax (KBr), cm1: 1600, 1630, 2925, 3120, 3410; dH
(300.13 MHz, DMSO-d6, 300 K): 7.58e7.63 (3H, m, 30,40,50-H),
8.05e8.10 (1H, m, 600-H), 8.18e8.21 (2H, m, 20,60-H), 8.54 (1H, s, 8-
H); dF (300.13 MHz, DMSO-d6): 134.68; 137.57; 145.34; 153.31.
Calcd for C17H7F4N5OS: C, 50.38; H, 1.74; F 18.75; N, 17.28; S, 7.91.
Found: C, 50.55; H, 1.86; F 18.52; N, 17.45; S, 7.85.
4.2.10 (Z)-Ethyl 7-(p-tolyl)-4H-pyrazolo[5,1-d][1,2,3,5]thiatriazin-4-
ylidenecarbamate (5p). Yield 0.15 g (96%), mp 122e124 C; nmax
(KBr), cm1: 1635, 2320, 2970, 3110, 3400; dH (300.13 MHz, DMSO-
d6, 300 K): 1.31 (3H, t, J 7.0 Hz,PCH2CH3), 2.40 (3H, s, CH3), 4.28 (2H,
q, J 7.0 Hz, PCH2CH3), 7.39 (2H, d, J 7.9 Hz, 30,50-H), 8.05 (2H, d, J
7.9 Hz, 20,60-H), 8.41 (1H, s, 8-H); dC (75.4 MHz, DMSO-d6, 300 K):
13.9, 21.0, 63.1, 109.9, 126.6, 126.9, 129.7, 140.5, 145.8, 155.2, 157.9,
160.8. Calcd for C14H13N5O2S: C, 53.32; H, 4.16; N, 22.21; S, 10.17.
Found: C, 53.38; H, 4.19; N, 22.33; S, 10.18.
4.2.11 (Z)-N-(7-(p-Tolyl)-4H-pyrazolo[5,1-d][1,2,3,5]thiatriazin-4-
ylidene)benzamide (5q). Yield 0.17 g (98%), mp 184e186 C; nmax
(KBr), cm1: 1625, 2350, 3125, 3450; dH (300.13 MHz, DMSO-d6,
300 K): 2.42 (3H, s, CH3), 7.43 (2H, d, J 7.9 Hz, 30,50-H), 7.63e7.67
(2H, m, 300,500-H), 7.73e7.77 (1H, m, 400-H), 8.13 (2H, d, J 7.9 Hz, 20,60-
H), 8.32 (2H, d, J 7.0 Hz, 200,600-H), 8.49 (1H, s, 8-H); dC (75.4 MHz,
DMSO-d6, 300 K): 21.0, 109.8, 126.7, 127.0, 129.0, 129.8, 130.2, 133.7,
134.2, 140.5, 146.0, 155.3, 157.5, 177.1. Calcd for C18H13N5OS: C,
62.23; H, 3.77; N, 20.16; S, 9.23. Found: C, 62.29; H, 3.81; N, 20.30; S,
9.28.
4.2.12 (Z)-2,3,4,5-Tetraﬂuoro-N-(7-p-tolyl-4H-pyrazolo[5,1-d][1,2,3,5]
thiatriazin-4-ylidene)-benzamide (5r). Yield 0.17 g (83%), mp
158e160 C, nmax (KBr), cm1: 1620, 2920, 2950, 3115, 3400; dH
(300.13MHz, DMSO-d6, 300 K): 2.44 (3H, s, CH3), 7.35 (2H, d, J 8.0Hz,
30,50-H), 8.08 (2H, d, J 8.0 Hz, 20,60-H), 8.10e8.18 (1H, m, 200-H), 8.34
(1H, s, 8-H), dF (300.13 MHz, DMSO-d6): 134.75; 137.62; 145.42;
153.35; dC (75.4MHz, DMSO-d6, 300 K): 21.6, 99.9,109.9,114.4,114.6,
118.5, 126.5, 127.1, 130.0, 141.7, 145.6, 146.2, 157.1, 158.4, 180.4.
Calcd for C18H9F4N5OS: C, 51.55; H, 2.16; F 18.12; N, 16.70; S, 7.65.
Found: C, 51.48; H, 2.08; F 18.32; N, 16.79; S, 7.56.
4.2.13 (Z)-Ethyl 7-(4-methoxyphenyl)-4H-pyrazolo[5,1-d][1,2,3,5]
thiatriazin-4-ylidenecarbamate (5s). Yield 0.12 g (70%), mp
144e146 C; nmax (KBr), cm1: 1645, 2340, 2975, 3125, 3450; dH
(300.13 MHz, DMSO-d6, 300 K): 1.37 (3H, t, J 7.0 Hz, OCH2CH3), 3.87
(3H, s, OCH3), 4.29 (2H, q, J 7.0 Hz, OCH2CH3), 7.05 (2H, d, J 8.9 Hz,
30,50-H), 8.08 (2H, d, J 8.9 Hz, 20,60-H), 8.26 (1H, s, 8-H); dC
(75.4 MHz, DMSO-d6, 300 K): 14.8, 56.2, 63.9, 110.6, 115.5, 122.9,
122.9, 129.2, 129.2, 146.7, 156.0, 162.0. Calcd for C14H13N5O3S: C,
50.75; H, 3.95; N, 21.14; S, 9.68. Found: C, 50.86; H, 4.02; N, 20.98; S,
9.59.
4.2.14 (Z)-N-(7-(40-Methoxyphenyl)-4H-pyrazolo[5,1-d][1,2,3,5]thia-
triazin-4-ylidene)-benzamide (5t). Yield 0.16 g (89%), mp
160e162 C; nmax (KBr), cm1: 1620, 2840, 2950, 3115, 3450; dH
(300.13 MHz, DMSO-d6, 300 K): 3.87 (3H, s, PCH3), 7.16 (2H, d, J
8.9 Hz, 30,50-H), 7.60e7.66 (2H, m, 300,500-H), 7.71e7.74 (1H, m, 400),
8.17 (2H, d, J 8.9 Hz, 20,60-H), 8.31 (2H, d, J 7.2 Hz, 200,600-H), 8.43
(1H, s, 8-H); dC (75.4 MHz, DMSO-d6, 300 K): 55.3, 109.6, 114.6,
122.1, 128.4, 128.9, 130.1, 133.7, 134.2, 145.9, 155.1, 157.3, 161.2,
E.V. Sadchikova et al. / Tetrahedron 69 (2013) 6987e69926992177.1. Calcd for C18H13N5O2S: C, 59.49; H, 3.61; N, 19.27; S, 8.82.
Found: C, 59.52; H, 3.63; N, 19.36; S, 8.88.
5. X-ray diffraction study of 5k
Crystals were grown from ethyl acetate. All measurements were
made on a Bruker SMART 6000 diffractometer equippedwith a CCD
detector using CuKa radiation (l¼1.54178 A). The crystal system of
compound 5k (C10H11N5O4S, M¼297.30) is orthorhombic, space
group Pbca, a¼8.6546(2), b¼7.8213(2), c¼37.2599(8) A, Z¼8,
V¼2522.13(10) A3, Dc¼1.566 g/cm3, F(000)¼1232, crystal size:
0.100.600.60 mm, m(CuKa)¼2.524 mm1, T¼373 K, 11,654 re-
ﬂections collected, 2356 unique reﬂections, Rint¼0.135. Final R in-
dices: R1¼0.0566 for 2123 reﬂections with I>2s(I) and R1¼0.0500,
wR2¼0.1522 for all data. Crystallographic data (excluding structure
factors) for this structure have been deposited with the Cambridge
Crystallographic Data Centre. Copies of the data can be obtained free
of charge on application to CCDC, 12 Union Road, Cambridge CB2
1EZ, UK (fax: þ44-1223-336033; e-mail: deposit@ccdc.cam.ac.uk).
6. Computational details
All calculations were performed by G09 suit.37 Structures were
initially optimized at B3LYP/6-31þG** level of theory. To prove the
true character of located minima, Hessian was calculated. No imagi-
nary frequencymodeswere found forall structures.NBOanalysiswas
done at the same level by NBO 3.0 module implemented in G09.38
Obtained B3LYP/6-31þG** densities were analyzed by AIM scheme
with a help of AIMAll software.39 gOpenMol40,41 and Gabedit42 soft-
ware were used for visualization of results.
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